PROMISSORY NOTE EXTENSIONPromissory Note Extension Agreement • February 6th, 2024 • Intellipharmaceutics International Inc. • Pharmaceutical preparations
TARO PHARMACEUTICALS INC. -and- INTELLIPHARMACEUTICS, CORP. LICENCE AND SUPPLY AGREEMENT Desvenlafaxine Extended-Release Tablets (50 mg and 100 mg desvenlafaxine succinate) FOR SALE IN CANADA LICENSE AND SUPPLY AGREEMENTLicence and Supply Agreement • February 6th, 2024 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • Ontario
THIS AGREEMENT, made as of July 29, 2022 (the “Effective Date”) between Taro Pharmaceuticals Inc., having its offices at 130 East Road, Brampton, Ontario, Canada, L6T 1C1 (“Taro”), and Intellipharmaceutics, Corp., having its offices at 30 Worcester Road, Toronto, Ontario, Canada M9W 5X2 (“IPC”). Taro and IPC are herein sometimes referred to individually as a “Party” and collectively as the “Parties”.
